Vivos Holdings, LLC

The company's capital structure is characterized by a debt-to-equity ratio of 0.0, indicating no long-term debt obligations. This is supported by a strong current ratio of 14.01, suggesting robust short-term liquidity. However, the company's operating cash flow is negative at -2,057,740, and its free cash flow is also negative at -3,168,840, indicating significant cash outflows from operations.

Profitability metrics reveal a challenging financial position. The company reported a net loss of -3,066,020 and an operating loss of -3,165,050, with a return on equity of -1.8461 and a return on assets of -1.6417. These figures are well below the industry norms for profitability and returns, suggesting the company is underperforming relative to its peers in the Advanced Medical Equipment & Technology industry.

Geographically and segment-wise, the company's revenue concentration is not disclosed in the available data. However, the absence of detailed segment or geographic breakdowns limits the ability to assess exposure to specific markets or product lines.

The company's growth trajectory is currently negative. The financial snapshot does not provide historical revenue data to calculate year-over-year growth, but the current financial performance, marked by significant losses and negative cash flows, suggests a contraction in operations.

Risk factors include low liquidity and the potential for dilution, although no immediate filing-based liquidity or dilution flags were detected. The company's negative operating and free cash flows indicate a need for external financing, which could lead to dilution if not managed through operational improvements or alternative funding sources.

Recent events, including filings and transcripts, do not show any significant developments that would alter the company's current financial trajectory. The absence of disclosed events suggests a lack of recent strategic or operational changes that could impact performance.